Minimizing cost associated with management of heparin-induced thrombocytopenia: A cost analysis of various laboratory testing models.
Kalynn A NorthamJasmine A JohnsonAllison BehrensSheh-Li ChenRaj S KasthuriMarian Rollins-RavalPublished in: International journal of laboratory hematology (2021)
Institutions should evaluate current HIT laboratory testing practices and assess for opportunities for optimization. Testing models utilizing a PF4-heparin antibody ELISA with a reflex SRA for positive results may improve testing metrics and lead to lower utilization of alternative anticoagulants.